Financial Review on Healthcare Stocks Teva Pharmaceutical Industries Ltd. and Allergan Inc. -- Drug Manufacturers Focusing on Expansion and Litigation

Thu Nov 1, 2012 9:39am EDT

* Reuters is not responsible for the content in this press release.

  NEW DELHI, INDIA, Nov 01 (Marketwire) -- 
The drug manufacturers -- other industry, which features companies such
as Teva Pharmaceutical Industries Limited and Allergan Inc., has been
operating under complex conditions as of late. Patent expirations
continue to negatively impact financials while research and development
remains costly and time consuming. The Drug Manufacturers - Other
industry has seen the above updates lately. And members can today access
complimentary reports for two companies, Teva Pharmaceutical Industries
Limited (NYSE: TEVA) and Allergan Inc. (NYSE: AGN), serving this industry
by following this link has brought together some of the best financial and
technical minds from around the biggest economies globally so that you
can have an array of free stock research and reporting. As the global
economy continues to experience colossal strain and unprecedented actions
are been taken by governments and the private sectors to survive and
boost the dwindling worldwide economic growth, our researchers give you
insight of how big players in different key sectors and industries of the
American exchanges are faring. Sign up now for your free membership at 

    On the legal side of things, battles over patent infringement cases have
led some companies higher while others have been dealt major setbacks.
Settlement agreements have been popular, though the ultimate problem of
loss of exclusivity is still a concern. Teva Pharmaceutical Industries
Limited financial analysis available by signing up for free at 

    To counter some of the aforementioned headwinds, several companies in the
industry have been expanding their operations abroad. Europe and Asia
have been popular expansion destinations, though Latin America is also
gaining in popularity. A number of companies have entered into strategic
alliances with foreign companies that are already established abroad,
which should make it easier for them to grow moving forward. posted financial analysis on Allergan Inc. today, members
can access it at 

    Getting the necessary approvals for their products is another story
though, and drug manufacturers that are able to team-up with foreign
businesses while also getting their products to market could be best

    About Street-Wire:
 Street-Wire aims to satisfy our new members with
timely knowledge and to provide veteran traders with innovative and
cognitive content when it comes to investing. We believe learning is a
two-way channel, and we learn from our members as much as we provide them
with what they need to make sense of the markets. We strive to introduce
investors to new analytical viewpoint before the market becomes aware of

    Read our Disclaimer 


Contact Person:
Anthony K. Merchant
Communications Executive 

Copyright 2012, Marketwire, All rights reserved.